How a Resilience-Focused Intervention is Perceived by Women Subjected to Domestic Violence (EMBER-2)

April 8, 2026 updated by: Uppsala University

Exploring Resilience. A Qualitative Study of an Intervention After Intimate Partner Violence.

At Uppsala University Hospital, there is an outpatient clinic for women subjected to intimate partner violence. In order to explore how patients experience the biopsychosocial resilience-based intervention in use at the clinic and how well the intervention fits the needs of the patients, 30 patients from different stages of their contact at the clinic and with diverse life situations and background are enrolled. The researchers will carry out individual in-person interviews, each lasting approximately 60 minutes, based on a semi-structured set of questions. The questions concern the participant´s life situation, resilience and self-perceived needs, how well the intervention has met those needs and how it was perceived by the participant. The interviews are audio-recorded and transcribed verbatim for thematic analysis.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Sweden
    • Uppsala County
      • Uppsala, Uppsala County, Sweden, 75185
        • Recruiting
        • Uppsala University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The participants are patients at the NCK outpatient clinic at Uppsala University Hospital, due to experiences of being subjected to intimate partner violence. Due to clinic admission criteria, the population is limited to women over 18 of age. Participants are enrolled by strategic sampling to assure a diverse sample across variables of health, age, ethnicity, socio-economy and time enrolled at the clinic.

Description

Inclusion Criteria:

  • Enrolled in the EMBER intervention at the NCK outpatient clinic.

Exclusion Criteria:

  • Any situation that, in the opinion of the Investigator, would compromise the safety of the patient or the quality of the data.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
EMBER-intervention participants
Women subjected to intimate partner violence at the NCK outpatient clinic
Behavioral: Qualitative interview
A semi-structured interview

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient experiences of EMBER
Time Frame: To be conducted at the time of enrollment
Interview questions exploring experiences and attitudes regarding the EMBER intervention
To be conducted at the time of enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Needs and resilience
Time Frame: to be conducted at the time of enrollment
Interview questions concerning perceptions and beliefs regarding what is needed for recovery after intimate partner violence
to be conducted at the time of enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uppsala University

Investigators

  • Principal Investigator: Carolina Överlien, Professor, The National Centre for Knowledge on Men's Violence Against Women, Uppsala university

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 7, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

March 1, 2027

Study Registration Dates

First Submitted

November 14, 2025

First Submitted That Met QC Criteria

November 14, 2025

First Posted (Actual)

November 19, 2025

Study Record Updates

Last Update Posted (Actual)

April 13, 2026

Last Update Submitted That Met QC Criteria

April 8, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • EMBER-2
  • 2025-04335-01 (Other Identifier: Swedish Ethical Review Authority)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intimate Partner Violence

Clinical Trials on Qualitative interview

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe